Variation in Early Anakinra Use and Short-term Outcomes in Multisystem inflammatory Syndrome in Children.
Joyce C ChangCameron C YoungEyal MuscalSara K Sexson TejtelMargaret M NewhamsSuden KucukakHillary CrandallAline B MadduxCourtney M RowanNatasha B HalasaHelen A HarveyCharlotte V HobbsMark W HallMichele KongCassyanne L AguiarJennifer E SchusterJulie C FitzgeraldAalok R SinghKari WellnitzRyan A NofzigerNatalie Z CvijanovichElizabeth H MackAdam J SchwarzSabrina HeidemannJane W NewburgerLaura D ZambranoAngela P CampbellManish M PatelAdrienne G RandolphMary Beth F Sonnull nullPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
We identified substantial variation in initial anakinra use in a real-world population of children with MIS-C, but no average short-term improvement in cardiovascular outcomes associated with early addition of anakinra to IVIG and/or glucocorticoids compared to IVIG and glucocorticoids alone.
Keyphrases